发明名称 Inhalable Medicament Comprising Tiotropium
摘要 This invention relates to a solution formulation comprising a tiotropium salt, 12-20% ethanol, 0.1-1.5% of water, 0.05-0.10% citric acid (or other organic acid) and an HFA propellant, wherein the percentages are percentages by weight based on the total weight of the formulation. The invention also provides a p MDI comprising a canister containing the formulation.
申请公布号 US2017020852(A1) 申请公布日期 2017.01.26
申请号 US201615285584 申请日期 2016.10.05
申请人 TEVA Branded Pharmaceutical Products R&D, Inc. 发明人 Zeng Xian-Ming
分类号 A61K31/439;A61K47/12;A61M15/00;A61K9/00;A61M11/02;A61K47/10;A61K47/06 主分类号 A61K31/439
代理机构 代理人
主权项
地址 Horsham PA US